The invention provides methods and compositions for the treatment of cancersassociated with overexpression of a BCL2 gene and/or gene product in a subject,and methods and compositions for the improvement of anti-cancer therapy, suchas chemotherapy and radiation therapy. The invention also encompasses methodsfor determining the efficacy of a cancer therapy in a subject and methods for inducingapoptosis of a cell.